摘要
目的探讨Neuroform Atlas支架辅助弹簧圈栓塞术治疗破裂宽颈前交通动脉瘤的有效性及安全性。方法山东第一医科大学附属人民医院神经外科自2022年1月至2023年6月应用Neuroform Atlas支架辅助弹簧圈栓塞术治疗32例破裂宽颈前交通动脉瘤患者,术后即刻行DSA检查,采用Raymond分级评估动脉瘤栓塞情况。末次随访时采用改良Rankin量表(mRS)评估患者预后(mRS评分≤2分定义为预后良好,mRS评分>2分定义为预后不良)。术后半年复查DSA,评估动脉瘤愈合情况。结果32例患者均成功完成支架辅助弹簧圈栓塞手术。术后即刻DSA检查显示动脉瘤栓塞程度均达到Raymond分级Ⅰ级(100%)。除1例患者术中动脉瘤破裂出血外,未出现支架内血栓、脑血管痉挛、支架打开不良等并发症。末次随访时患者预后良好31例,预后不良1例。22例患者接受DSA复查,结果显示Raymond分级Ⅰ级20例(90.91%),Ⅱ级2例(9.09%)。结论应用Neuroform Atlas支架辅助弹簧圈栓塞术治疗破裂宽颈前交通动脉瘤安全有效。
Objective To explore the efficacy and safety of Neuroform Atlas stent-assisted coil embolization in ruptured anterior communicating wide-necked aneurysms.Methods Thirty-two patients with ruptured anterior communicating wide-necked aneurysms accepted Neuroform Atlas stent assisted coil embolization in Department of Neurosurgery,People's Hospital Affiliated to Shandong First Medical University from January 2022 to June 2023 were chosen.DSA was performed immediately after surgery,and aneurysm embolization was assessed using Raymond grading.Prognoses were assessed by modified Rankin Scale(mRS,mRS scores≤2 as good prognosis and mRS scores>2 as poor prognosis)at last follow-up.DSA was performed again 6 months after surgery to assess the aneurysm healing Results Neuroform Atlas stents were successfully implanted in all 32 patients;Postoperative DSA showed that aneurysm embolization reached Raymond grading I in all 32 patients(100%).No such complications as in-stent thrombosis,cerebral vasospasm,or poor opening of the stent were noted excepted for one with intraoperative aneurysm rupture hemorrhage.At the last follow-up,31 patients had good prognosis and 1 had poor prognosis;in 22 patients underwent DSA re-examination,Raymond grading I was noted in 20 patients(90.91%)and grading II in 2(9.09%).Conclusion Neuroform Atlas stent-assisted coil embolization for ruptured anterior communicating wide-necked aneurysms seems safe and effective.
作者
姜宗飞
刘振瑞
李逢佳
司锋
朱军
高勇
鹿向东
宋纯玉
Jiang Zongfei;Liu Zhenrui;Li Fengjia;Si Feng;Zhu Jun;Gao Yong;Lu Xiangdong;Song Chunyu(Department of Neurosurgery,Ji'nan Key Laboratory of Neuro-oncology Molecular Biology,People's Hospital Affiliated to Shandong First Medical University(Ji'nan People's Hospital),Ji'nan 271199,China)
出处
《中华神经医学杂志》
CAS
CSCD
北大核心
2024年第5期484-488,共5页
Chinese Journal of Neuromedicine
基金
山东省老年医学学会科技攻关项目(LEJGG202W058)
济南市临床医学科技创新计划(202134057、202225040)。
